Logo.png
Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight
07. Oktober 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight  The market for B7-H3 inhibitors is expected to grow...
Logo.png
Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight
03. Oktober 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The increasing incidence of respiratory...
Logo.png
SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy Progress of Other Oral SERDs, During the Study Period (2020–2034) | DelveInsight
02. Oktober 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy...
Logo.png
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
01. Oktober 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Logo.png
KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight
30. September 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight  According to DelveInsight’s analysis, the growth of the KRAS...
Logo.png
Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight
26. September 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight The nicotine...
Logo.png
Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight
25. September 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight  The sarcopenia market...
Logo.png
Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
24. September 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Logo.png
Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
23. September 2024 11:30 ET | DelveInsight Business Research LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies...
Logo.png
Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight
23. September 2024 06:30 ET | DelveInsight Business Research LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Global Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight The growing demand for corporate wellness is largely driven...